Composition and transdermal drug delivery device

Details for Australian Patent Application No. 2002329763 (hide)

Owner Lavipharm Laboratories Inc.

Inventors Malik, Vinod; Osborne, James; Brown, Teletha A; Rudella, Michael; Hunt, Brian

Agent Callinan

Pub. Number AU-B-2002329763

PCT Number PCT/US02/26094

PCT Pub. Number WO2003/015678

Priority 60/313,055 17.08.01 US

Filing date 15 August 2002

Wipo publication date 3 March 2003

Acceptance publication date 8 November 2007

International Classifications

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/00 (2006.01)

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 60/313,055 17.08.01 US

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002329763

8 November 2007 Application Accepted

  Published as AU-B-2002329763

6 March 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002329764-CONNECTION MODULE

2002329762-Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide